TONI, Giulia
 Distribuzione geografica
Continente #
EU - Europa 15.484
NA - Nord America 5.581
AS - Asia 3.407
SA - Sud America 515
AF - Africa 82
OC - Oceania 19
AN - Antartide 2
Continente sconosciuto - Info sul continente non disponibili 2
Totale 25.092
Nazione #
IT - Italia 12.909
US - Stati Uniti d'America 5.429
SG - Singapore 1.203
CN - Cina 840
NL - Olanda 550
DE - Germania 469
BR - Brasile 410
FR - Francia 359
VN - Vietnam 356
UA - Ucraina 323
HK - Hong Kong 254
TR - Turchia 214
GB - Regno Unito 181
FI - Finlandia 167
BD - Bangladesh 106
IN - India 103
RU - Federazione Russa 93
JP - Giappone 78
CA - Canada 71
CH - Svizzera 71
SE - Svezia 70
MX - Messico 60
ES - Italia 53
PL - Polonia 51
ID - Indonesia 45
AR - Argentina 35
BE - Belgio 27
IQ - Iraq 24
TH - Thailandia 21
RO - Romania 19
ZA - Sudafrica 19
AU - Australia 17
CO - Colombia 16
AT - Austria 15
EC - Ecuador 15
MY - Malesia 15
DK - Danimarca 14
IR - Iran 14
KR - Corea 14
LT - Lituania 14
MA - Marocco 14
PH - Filippine 14
AE - Emirati Arabi Uniti 13
CZ - Repubblica Ceca 13
IE - Irlanda 13
UZ - Uzbekistan 13
CL - Cile 12
GR - Grecia 12
IL - Israele 12
PK - Pakistan 12
SA - Arabia Saudita 12
BO - Bolivia 8
TW - Taiwan 8
VE - Venezuela 8
AL - Albania 7
KE - Kenya 7
TN - Tunisia 7
DZ - Algeria 6
EG - Egitto 6
JO - Giordania 6
MT - Malta 6
PT - Portogallo 6
SK - Slovacchia (Repubblica Slovacca) 6
LB - Libano 5
NO - Norvegia 5
AZ - Azerbaigian 4
BY - Bielorussia 4
MD - Moldavia 4
OM - Oman 4
PE - Perù 4
UY - Uruguay 4
AO - Angola 3
CI - Costa d'Avorio 3
CY - Cipro 3
DO - Repubblica Dominicana 3
HR - Croazia 3
JM - Giamaica 3
KZ - Kazakistan 3
LU - Lussemburgo 3
LV - Lettonia 3
NG - Nigeria 3
NP - Nepal 3
PA - Panama 3
PY - Paraguay 3
RS - Serbia 3
SI - Slovenia 3
SM - San Marino 3
AQ - Antartide 2
CR - Costa Rica 2
ET - Etiopia 2
EU - Europa 2
GE - Georgia 2
GT - Guatemala 2
HU - Ungheria 2
LY - Libia 2
NZ - Nuova Zelanda 2
SN - Senegal 2
TT - Trinidad e Tobago 2
AG - Antigua e Barbuda 1
BB - Barbados 1
Totale 25.071
Città #
Milan 1.057
Rome 791
Singapore 739
Ashburn 582
San Jose 435
Fairfield 372
Woodbridge 319
Beijing 295
Chandler 270
Jacksonville 263
Santa Clara 258
Dallas 249
Hong Kong 244
Naples 220
Houston 208
Turin 186
Bologna 175
Ann Arbor 163
Florence 162
Seattle 156
Munich 153
Wilmington 148
Bari 136
Cambridge 136
Palermo 130
Izmir 123
Ho Chi Minh City 113
Brescia 106
Hanoi 101
Helsinki 96
Ferrara 93
New York 83
Catania 82
Genoa 81
Los Angeles 81
Nanjing 80
Verona 79
Tokyo 75
Bremen 65
Padova 65
Princeton 63
Lauterbourg 60
Redwood City 60
Modena 58
Cagliari 57
Perugia 57
Parma 54
Dearborn 51
Bergamo 45
Boardman 45
Shanghai 45
The Dalles 39
Reggio Emilia 38
São Paulo 37
Chicago 35
Pescara 35
Trento 35
Trieste 35
Venice 34
Monza 32
Salerno 32
Falkenstein 31
Treviso 30
Mexico City 29
Orem 29
Pisa 29
San Diego 29
Napoli 28
Council Bluffs 27
London 27
Tianjin 27
Rimini 26
Amsterdam 25
Toronto 25
Lucca 24
Mountain View 23
Warsaw 23
Nanchang 22
Taranto 22
Bolzano 21
Chennai 21
Moscow 21
Shenyang 20
Torino 20
Washington 20
Jiaxing 19
Reggio Calabria 18
Vicenza 18
Cinisello Balsamo 17
Jakarta 17
Lamezia Terme 17
Livorno 17
Manchester 17
Afragola 16
Ancona 16
Como 16
Haiphong 16
Meda 16
Montreal 16
Novara 16
Totale 10.968
Nome #
Ustioni da airbag: una problematica emergente 10.593
Maintenance therapy: A crucial strategy in acne treatment 1.558
Linfangioma circoscritto vulvare: quando le cose si complicano. 1.014
Cinquanta sfumature di blu. 591
Anti-infiammatori non steroidei nell’acne: quale razionale? 498
Possibili marcatori di malattia e prognosi nel lichen sclerosus vulvare: il contributo dell’epigenetica. 414
Clobetasol propionate vs. mometasone furoate in 1-year proactive maintenance therapy of vulvar lichen sclerosus: Results from a comparative trial 397
Anatomia e fisiologia dell’unità pilo-sebacea 319
null 309
Effect of Corticosteroid Phobia on Treatment Adherence and Outcome in Women With Lichen Sclerosus: A Prospective Study 267
Oral clindamycin and rifampicin in the treatment of hidradenitis suppurativa-acne inversa: a prospective study on 23 patients. 226
Safe use of oral isotretinoin after pseudo-tumor cerebri due to minocycline. 218
Insect repellents and contact sensitization: An observational study 215
Side-effects of tango: Connubial contact dermatitis 213
Maintenance therapy for acne vulgaris: efficacy of a 12-month treatment with adapalene-benzoyl peroxide after oral isotretinoin and a review of the literature. 211
Clinical and dermoscopic changes of vulvar lichen sclerosus after topical corticosteroid treatment 205
Dermoscopy of patch test reactions: study of applicability in differential diagnosis between allergic and irritant reactions 205
Avocado and soybean extracts as active principles in the treatment of mild-to-moderate vulvar lichen sclerosus: Results of efficacy and tolerability 198
Clearance in vulvar lichen sclerosus: a realistic treatment endpoint or a chimera? 195
Combining topical tretinoin with mometasone furoate in the treatment of vulvar lichen sclerosus: Results of dermoscopic assessment 189
Efficacy and safety of a 12-month treatment with a combination of hydroxypinacolone retinoate and retinol glycospheres as maintenance therapy in acne patients after oral isotretinoin 179
Severe vulvovaginal allergic contact dermatitis due to clotrimazole contained in multiple topical products 178
Hidradenitis Suppurativa: The Effect Of Combinated Treatment With Oral Clindamycin And Rifampicin 177
Adapalene 0.1% / benzoyl peroxide 2.5% gel fixed combination after oral isotretinoin: evaluation of acne recurrence incidence. 177
Combined therapy in vulvar lichen sclerosus: does topical tretinoin improve the efficacy of mometasone furoate? 177
Aromatherapy and occupational allergic contact dermatitis: Two further cases caused by lavender oil and other essential oils 175
Acne e retinoidi: come e quando impiegarli. 172
An update on hidradenitis suppurativa treatment. 171
Systemic allergic dermatitis due to gentamicin 166
Mometasone furoate in the treatment of vulvar lichen sclerosus: could its formulation influence efficacy, tolerability and adherence to treatment? 164
Level of use and safety of botanical products for itching vulvar dermatoses. Are patch tests useful? 162
I corticosteroidi sistemici nell’acne: perché, quando, come. 153
Cortisonici a confronto. 153
Consensus conference su isotretinoina orale. 153
Plasma cell vulvitis: further confirmation of the diagnostic utility of dermoscopy 153
Low-cumulative dose isotretinoin treatment in mild to moderate acne. 151
Cryogenic burn by cryolipolysis [Ustione a frigore da criolipolisi] 151
null 149
Bullous irritant contact dermatitis caused by an alcoholic extract from Juglans regia leaves 149
What’s new in acne? New therapeutic approaches. 148
Acne meccanica da tutore ortopedico. 147
Patch test reactions through the lens of dermoscopy: Further insights, particularly on weak allergic reactions 147
Mammary pigmented Paget's disease in a male: A diagnostic challenge 145
La biopsia del corneo nello studio dei comedoni. 144
Prospective clinical and epidemiologic study of vulvar lichen sclerosus: analysis of prevalence and severity of clinical features, together with historical and demographic associations. 143
Proposal for post-acne scar management algorithm. 137
Does longer duration of corticosteroid treatment improve clearance in vulvar lichen sclerosus? Results from a single centre, comparative, open label study 136
Cheiliti da contatto 136
It looks like acne, but… 130
Effectiveness of silk fabric underwear as an adjuvant tool in the management of vulvar lichen simplex chronicus: results of a double-blind randomized controlled trial 130
Radiation-induced angiosarcoma of the breast: an uncommon polymorphic disorder 129
Maintenance therapy in acne 126
What treatments are on the horizon for acne. 125
Topical treatment of acne: immunomodulatory approaches. 123
Rosacea Fulminans. 122
Does Clearance of Vulvar Lichen Sclerosus after a Corticosteroid Treatment Correspond to a Decrease in Disease-Related Burden? Results from a Cohort Study Using Pictorial Representation of Illness and Self-Measure and the Dermatology Life Quality Index 119
Micosi profonda ed iperplasia pseudolinfomatosa. 115
null 112
Umbilical nodules: Two cases of atypical cutaneous endometriosis 112
Dermoscopy of vulvar multiple syringomas: a diagnostic aid for a rare entity 109
Pioderma gangrenoso recidivante del volto trattato con dapsone. 109
Hidradenitis suppurativa: medical and surgical therapy review. 108
Lichen sclerosus vulvare: caratteristiche clinico-epidemiologiche, fattori di rischio ed elementi prognostici in pazienti seguite c/o l’ambulatorio di patologia vulvare. 105
Topical Corticosteroid Phobia Among Women Affected With Vulvar Lichen Sclerosus: Results From a Cross-sectional Survey 105
Successful treatment of ectropion induced by actinic keratoses with photodynamic therapy: Report of two cases 104
Proposal of a self-assessment questionnaire for the diagnosis of sensitive skin 103
When traditional Chinese medicine runs on WhatsApp® 102
null 95
Paget mammario pigmentato 95
Continuous vs. tapering application of the potent topical corticosteroid mometasone furoate in the treatment of vulvar lichen sclerosus: Results of a randomized trial 94
Searching for a “Window of Opportunity” in the Treatment of Vulvar Lichen Sclerosus: Evidence for Therapeutic Benefits of an Early Corticosteroid Treatment 86
Dermoscopy in plasma cell balanitis: its usefulness in diagnosis and follow-up. 85
null 83
Real-World Safety of Oral Isotretinoin in Patients During Sunny Months: Retrospective Cohort Study 79
Onychomadesis following hand, foot, and mouth disease: a case report from Italy and review of the literature. 70
Totale 25.303
Categoria #
all - tutte 65.732
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 883
Totale 66.615


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021163 0 0 0 0 0 0 0 0 0 0 0 163
2021/20221.761 154 205 135 151 129 81 115 94 90 147 141 319
2022/20232.570 223 188 126 191 237 208 184 165 229 177 271 371
2023/20243.792 352 395 329 291 245 279 234 235 189 349 443 451
2024/20255.051 539 500 458 291 495 406 316 352 505 423 392 374
2025/20266.548 620 381 615 664 840 478 735 400 531 731 321 232
Totale 25.303